Carcinoma, Squamous Cell: all 1,779 studies
Page 15 of 18. Open to participants first (409), then studies with results posted, then the rest; newest registration first within each.
- Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral CavityWithdrawnNCT02295540Not applicable
- A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC PatientsTerminatedNCT02285543Phase 2
- Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)CompletedNCT02282371Phase 1
- Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG)TerminatedNCT02279576Phase 2
- Dual-Energy CT in Patients With Head and Neck Squamous Cell CarcinomasCompletedNCT02279459
- Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT02277197Phase 1
- Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell CarcinomaTerminatedNCT02277184Phase 1
- Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell CarcinomaWithdrawnNCT02272699Phase 2/3
- Neck Dissection Via a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynxCompletedNCT02269020Phase 1
- Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell CancerStatus unknownNCT02268747Phase 2
- A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 (Durvalumab) With Tremelimumab in Head and Neck CancerCompletedNCT02262741Phase 1
- Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or EsophagusTerminatedNCT02254044Phase 1
- Single Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT02254018Phase 1
- Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung CancerCompletedNCT02245100
- State of the Art Photon Therapy Versus Particle Therapy for Recurrent Head & Neck Tumors; a Planning StudyCompletedNCT02242916
- Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and NeckTerminatedNCT02236936Phase 3
- Olaparib and Radiotherapy in Head and Neck CancerActive, not recruitingNCT02229656Phase 1
- Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNAWithdrawnNCT02211027Phase 1
- Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab TherapyTerminatedNCT02205398Phase 1
- Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and NeckTerminatedNCT02201355Phase 1
- Window Trial 5-aza in HNSCC, T-tareCompletedNCT02178072Phase 1
- Intensive Nutrition Counselling in Patients With Head and Neck CancerStatus unknownNCT02159508Not applicable
- Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and NeckCompletedNCT02158234Phase 1
- Identification of Breath Biomarkers in Head and Neck Squamous Cell CarcinomaSuspendedNCT02156180
- A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and NeckCompletedNCT02149602
- Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell CarcinomaCompletedNCT02147418
- ART: Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapyCompletedNCT02145416
- An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy.Status unknownNCT02145312Phase 2
- Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma PatientsWithdrawnNCT02143622Phase 1/2
- Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell CarcinomaCompletedNCT02131805Not applicable
- The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer StudyStatus unknownNCT02126189
- Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell CarcinomaStatus unknownNCT02123381Phase 2
- Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell CarcinomaStatus unknownNCT02119559Not applicable
- A Study of Intensity-modulated Radiotherapy in Patients With Squamous Cell Carcinoma of Unknown Primary (SCCUP) of the Head and NeckCompletedNCT02112344Not applicable
- Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and NeckTerminatedNCT02110992Phase 1
- Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck CancerCompletedNCT02107235Phase 1
- Aggressive Squamous Cell Carcinoma in Organ Transplant RecipientsCompletedNCT02095912
- Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell CarcinomaCompletedNCT02088515Phase 4
- Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic UncouplingCompletedNCT02083692Early Phase 1
- Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and NeckCompletedNCT02061631Phase 2
- SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHNCompletedNCT02057107Phase 2
- A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and HypopharynxCompletedNCT02055989Phase 1/2
- A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and NeckStatus unknownNCT02054442Phase 1/2
- International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly PaclitaxelStatus unknownNCT02051868Phase 2
- Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx CancerCompletedNCT02048020Phase 2
- Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCCCompletedNCT02047201Phase 2
- Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)TerminatedNCT02045186Not applicable
- Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of EsophagusWithdrawnNCT02041819Phase 2
- Interest of Narrow Band Imaging in Detection of Upper Aerodigestive CancersCompletedNCT02035735Not applicable
- Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02035527Phase 1
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of EsophagusWithdrawnNCT02033538Phase 2
- Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer PatientsCompletedNCT02025062Not applicable
- Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous CancerStatus unknownNCT02025036Phase 3
- Debio 1143-201 Dose-finding and Efficacy Phase I/II TrialCompletedNCT02022098Not applicable
- Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersCompletedNCT02020707Phase 1
- Does the Harmonic Scalpel Reduce Blood Loss and OR Time in Major Head and Neck Cancer Surgery Undergoing Major Surgery for Oral Cavity Squamous Cell Carcinoma?CompletedNCT02017834Not applicable
- A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the EsophagusTerminatedNCT02017600Phase 2
- Sequential Paclitaxel Chemotherapy and Radiotherapy as 1st Line Treatment for Elderly Esophageal Squamous Cell CancerStatus unknownNCT02016287Phase 2
- Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell CancerStatus unknownNCT02016274Phase 2
- Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and NeckTerminatedNCT02015650Phase 4
- Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)WithdrawnNCT02014831Phase 2
- A Study of DKN-01 in Combination With Paclitaxel or PembrolizumabCompletedNCT02013154Phase 1
- The Role of microRNA-29b in the Oral Squamous Cell CarcinomaStatus unknownNCT02009852
- Prospective Trial of Serial CT Imaging for Evaluation of Dosimetric/Volumetric Changes During IMRT for Head/Neck CancerCompletedNCT02003482
- Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma.Status unknownNCT01993784Phase 1/2
- MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical CancerTerminatedNCT01992861
- Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell CarcinomaStatus unknownNCT01987934
- Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"Status unknownNCT01976468
- Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung CancerStatus unknownNCT01969955Phase 2
- Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal CancerWithdrawnNCT01953952Phase 2
- NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)CompletedNCT01950689Phase 3
- Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal CancerTerminatedNCT01949740
- Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung CarcinomaStatus unknownNCT01947062Phase 3
- The Study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders and a Prognostic Marker for Oral Squamous Cell CarcinomaStatus unknownNCT01946230
- Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer PatientsCompletedNCT01941992Phase 2
- A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal.CompletedNCT01941966Phase 2
- Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck CancerCompletedNCT01935921Phase 1
- Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.Status unknownNCT01927354
- A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & NeckCompletedNCT01921426Phase 1
- Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell CancerCompletedNCT01914900Phase 2
- A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)CompletedNCT01911598Phase 1
- Nanocytology Test to Evaluate Skin Cancer in High Risk PatientsCompletedNCT01905891Not applicable
- Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNNCompletedNCT01884259Phase 2
- AF CRT +/- Nimorazole in HNSCCStatus unknownNCT01880359Phase 3
- A Prospective Study of Prophylactic Gastrostomy in Head and Neck Cancer Patients Undergoing ChemoradiotherapyTerminatedNCT01876693Not applicable
- Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCCStatus unknownNCT01874171Phase 3
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the LungStatus unknownNCT01872403Phase 2
- Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCCCompletedNCT01864850Phase 3
- Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCCCompletedNCT01864772Phase 2
- Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell CarcinomaStatus unknownNCT01855451Phase 3
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck CancerCompletedNCT01847326Phase 1
- Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast CancerCompletedNCT01846091Phase 1
- Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal CanalTerminatedNCT01843452Phase 2
- Study of S-1 in Combination With Radiotherapy in Esophageal CancerCompletedNCT01831531Phase 2
- Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and NeckStatus unknownNCT01830556Phase 2
- Pathological Validation of Functional Imaging in Head and Neck Squamous Cell CarcinomaTerminatedNCT01827709Not applicable
- Squamous Cell Carcinoma Antigen Analysis at the University Hospital OstravaCompletedNCT01827423Not applicable
- Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)CompletedNCT01822613Phase 1
- A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT)WithdrawnNCT01820312Phase 2
- Efficacy and Safety of TORS for SCCAActive, not recruitingNCT01819480Not applicable